CVS Health Statistics

Total Valuation

CVS Health has a market cap or net worth of GBP 76.84 billion. The enterprise value is 128.31 billion.

Market Cap	76.84B
Enterprise Value	128.31B

Important Dates

The next estimated earnings date is Wednesday, May 6, 2026.

Earnings Date	May 6, 2026
Ex-Dividend Date	Apr 23, 2026

Share Statistics

Current Share Class	1.28B
Shares Outstanding	n/a
Shares Change (YoY)	+0.71%
Shares Change (QoQ)	+0.63%
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	88.95%
Float	1.28B

Valuation Ratios

The trailing PE ratio is 58.49 and the forward PE ratio is 11.29.

PE Ratio	58.49
Forward PE	11.29
PS Ratio	0.26
PB Ratio	1.37
P/TBV Ratio	n/a
P/FCF Ratio	13.25
P/OCF Ratio	9.72
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.82, with an EV/FCF ratio of 22.12.

EV / Earnings	97.68
EV / Sales	0.43
EV / EBITDA	9.82
EV / EBIT	17.30
EV / FCF	22.12

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.06.

Current Ratio	0.84
Quick Ratio	0.57
Debt / Equity	1.06
Debt / EBITDA	4.53
Debt / FCF	10.24
Interest Coverage	3.21

Financial Efficiency

Return on equity (ROE) is 2.29% and return on invested capital (ROIC) is 5.62%.

Return on Equity (ROE)	2.29%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	5.62%
Return on Capital Employed (ROCE)	6.08%
Weighted Average Cost of Capital (WACC)	5.34%
Revenue Per Employee	1.14M
Profits Per Employee	5,062
Employee Count	259,500
Asset Turnover	1.58
Inventory Turnover	18.56

Taxes

In the past 12 months, CVS Health has paid 303.14 million in taxes.

Income Tax	303.14M
Effective Tax Rate	19.10%

Stock Price Statistics

The stock price has increased by +18.68% in the last 52 weeks. The beta is 0.51, so CVS Health's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	+18.68%
50-Day Moving Average	76.23
200-Day Moving Average	75.26
Relative Strength Index (RSI)	53.61
Average Volume (20 Days)	3,091

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.26

Income Statement

In the last 12 months, CVS Health had revenue of GBP 297.08 billion and earned 1.31 billion in profits. Earnings per share was 1.03.

Revenue	297.08B
Gross Profit	39.47B
Operating Income	7.44B
Pretax Income	1.59B
Net Income	1.31B
EBITDA	10.87B
EBIT	7.44B
Earnings Per Share (EPS)	1.03

Balance Sheet

The company has 7.87 billion in cash and 59.40 billion in debt, giving a net cash position of -51.53 billion.

Cash & Cash Equivalents	7.87B
Total Debt	59.40B
Net Cash	-51.53B
Net Cash Per Share	n/a
Equity (Book Value)	56.01B
Book Value Per Share	43.97
Working Capital	-10.39B

Cash Flow

In the last 12 months, operating cash flow was 7.90 billion and capital expenditures -2.10 billion, giving a free cash flow of 5.80 billion.

Operating Cash Flow	7.90B
Capital Expenditures	-2.10B
Depreciation & Amortization	3.41B
Net Borrowing	-1.32B
Free Cash Flow	5.80B
FCF Per Share	n/a

Margins

Gross margin is 13.29%, with operating and profit margins of 2.51% and 0.44%.

Gross Margin	13.29%
Operating Margin	2.51%
Pretax Margin	0.53%
Profit Margin	0.44%
EBITDA Margin	3.66%
EBIT Margin	2.51%
FCF Margin	1.95%

Dividends & Yields

This stock pays an annual dividend of 1.98, which amounts to a dividend yield of 2.52%.

Dividend Per Share	1.98
Dividend Yield	2.52%
Dividend Growth (YoY)	-4.18%
Years of Dividend Growth	n/a
Payout Ratio	192.14%
Buyback Yield	-0.71%
Shareholder Yield	1.81%
Earnings Yield	1.71%
FCF Yield	7.55%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

CVS Health has an Altman Z-Score of 2.27 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.27
Piotroski F-Score	7